Podcast appearances and mentions of Peter Marks

Peter Marks, software developer and technology commentator from Access Informatics, joins Chris Taylor to discuss Israeli military technology.

Peter Marks, software developer and technology commentator from Access Informatics joined James O'Loghlin on Nightlife

On this week's episode, Grace Colón, Josh Schimmer, Sam Fazeli, Tess Cameron, Eric Schmidt, and Yaron Werber kick off with a discussion on recent policy moves including the appointment of Vinay Prasad as the director of the FDA's CBER division and nomination of Casey Means for U.S. Surgeon General, noting the impact on the XBI and uncertainty around vaccine gene therapy approvals. The group pondered what kind of regulator Prasad may be, predicting a stricter approach than his predecessor, Peter Marks. The conversation covered the shifting dynamics in vaccine approvals under the new FDA leadership, highlighting that delays like Novavax's flu combo signal heightened scrutiny, with mRNA follow-ons likely to pass under stricter labels, while new vaccines face raised efficacy bars. On the policy front, Trump's proposed “Most Favored Nation” drug pricing strategy raises alarms over a potential trillion-dollar hit to innovation and unintended consequences for U.S. drug prices. The conversation shifts to early data on Genocury's in vivo CAR-T, PTC's mixed Huntington's disease results, and Krystal's gene therapy for neuropathic keratitis. The episode concludes with a roundup of Q1 earnings results. *This episode aired on May 9, 2025.

Eating crickets and meat grown in a lab with cancer-like cells - WHO APPROVED THAT?! Scott Tips, president of the National Health Federation (NHF) and internationally recognized health freedom attorney, joins host, Jamie Belz, to help us understand the deeper mechanisms of Codex Alimentarius, the World Trade Organization (WTO), and the global regulatory web that threatens access to nutrient-dense food, natural health remedies, and therapeutic supplements.   As the only health-freedom organization with official INGO (International Non-Governmental Organization) status at Codex, NHF is uniquely positioned to stand up for the public's right to safe, informed, and autonomous healthcare choices on the global stage.   Over the last 70 years, NHF has defended medical choice and challenged the federal government's overreach into nutrition, supplementation, and holistic healing.   Some quick topics/snippets from this episode: Codex creates international food law—affecting everything from vitamin dosage limits to whether or not your meat contains drug residues. Most people don't even know Codex exists. And yet, decisions made there determine what shows up in your grocery cart, your supplement bottle, and your child's plate. The U.S. can now force genetically modified foods into countries that don't want them — not through diplomacy, but through international tribunals using Codex standards as their weapon. Ractopamine is a drug with zero therapeutic value. It makes animals fatter, faster — but it's banned in the EU, China, and Russia. In the U.S., you're probably eating it. When you hear ‘scientific consensus,' be cautious. The phrase is used to bulldoze public concern. You can be banned for calling out corruption at Codex. At CODEX, NHF is the only one defending your right to natural health freedom. The EU, Russia, even Iran — they've stood up for consumer safety at Codex more than the U.S. delegates have. The scary thing isn't just what the FDA is doing. It's how many people still trust them, blindly — even when their actions have harmed more people than every U.S. war combined. We need advocacy from the ground up. Most parents feeding their kids toxic food don't even know it — because the truth has been buried. “Frankenmeat”, insect protein, and natural flavoring cover-ups, all of which bypass transparent labeling laws while being quietly introduced into the food supply. They're trying to outlaw homeopathy—while promoting lab-grown meat and insect protein as sustainable alternatives. We don't want to be right. We want to get it right.   “Unless we put medical freedom into the Constitution, the time will come when medicine will organize into an undercover dictatorship… To restrict the art of healing to one class of men and deny equal privileges to others will constitute the Bastille of medical science. All such laws are un-American and despotic.” - Dr. Benjamin Rush, Declaration of Independence signator and Surgeon General of the Continental Army   "If people let the government decide what foods they eat and what medicines they take, their bodies will soon be in as sorry a state as the souls of those who live under tyranny.” - Thomas Jefferson   TAKE ACTION:  Join the National Health Federation for only $45/year to support international advocacy at Codex and receive the quarterly NHF magazine. This low-cost membership helps fund independent watchdog efforts that no other organization is legally authorized to perform at the global level. ⁠JOIN HERE⁠   Other mentions: ⁠⁠Ep 034: Fight For Your Right To Health Freedom⁠⁠ ⁠The HighWire report exposing Peter Marks and vaccine data suppression⁠    Health freedom is necessary. As government and corporate interests grow more entangled, grassroots advocacy is no longer optional. It's essential. Join the NHF and become part of the movement to reclaim sovereignty over what we eat, how we heal, and what we're allowed to know.    

Peter Marks, a software developer and technology commentator from Access Informatics, joined Chris Taylor on Nightlife to discuss the latest news in technology. 

The FBI arrests alleged child predators. The Food and Drug Administration (FDA) hires a new top vaccine official to replace Dr. Peter Marks. And the Department of Government Efficiency's (DOGE) effort has hit a new milestone, as well as a new legal snag. Let's go through a full update on today's episode of Facts Matter.Episode Resources:

Doctors announced this week that they have treated a newborn baby with a rare genetic disease using the world’s first personalized gene editing therapy. Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Doctors announced this week that they have treated a newborn baby with a rare genetic disease using the world’s first personalized gene editing therapy. Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Echo Garden - May 2025 Mix by Peter Marks

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – If the news is accurate that the nominee for Surgeon General, Casey Means, is pregnant, I hope she avoids the COVID shot for her child and tells the world why. The new FDA vaccine director, Dr. Vinay Prasad, replaces the fraudulent Peter Marks and is immediately called an ‘anti-vaxxer' despite decades of giving them to his patients...

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – If the news is accurate that the nominee for Surgeon General, Casey Means, is pregnant, I hope she avoids the COVID shot for her child and tells the world why. The new FDA vaccine director, Dr. Vinay Prasad, replaces the fraudulent Peter Marks and is immediately called an ‘anti-vaxxer' despite decades of giving them to his patients...

Nurses Out Loud – No press conference. No accountability. Just a quiet exit from the man who greenlit experimental technology injected into hundreds of millions of Americans, including children. But this resignation isn't just about one man. It's about a system that shields itself from responsibility while silencing dissent. Dr. Peter Marks wasn't simply a figurehead...

Nurses Out Loud – No press conference. No accountability. Just a quiet exit from the man who greenlit experimental technology injected into hundreds of millions of Americans, including children. But this resignation isn't just about one man. It's about a system that shields itself from responsibility while silencing dissent. Dr. Peter Marks wasn't simply a figurehead...

Del recaps ICAN's explosive D.C. press conference exposing former FDA official Dr. Peter Marks for blocking recognition and support for the COVID-19 vaccine injured. Jefferey Jaxen reports on the health freedom movement sweeping U.S. states, a perplexing power outage in Spain and Portugal, and new fertility concerns tied to the COVID shot. Del is joined by John Miller to preview the 2025 Food Independence Summit: Seed to Spoon, celebrating America's growing self-sufficiency movement.Guest: John MillerBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Daar is 935 bevestigde gevalle van masels in die VSA, met uitbrekings in ses state en gevalle wat in 23 ander aangemeld is. Drie mense, insluitend twee kinders, is dood waarvan nie een ingeënt is nie. Amerika se afgedankte entstofhoof, dr. Peter Marks het aan Sky News gesê daar sal meer sterftes wees tensy die Amerikaanse regering sy retoriek oor inenting verander.

Artificial intelligence continues to revolutionise our lives. Predictions from experts state that Ai will likely automate or transform 50% to 60% of jobs. 

PRESS REVIEW – Thursday, May 1: The Spanish papers continue to wonder what – or who – was responsible for the Great Blackout that plunged Spain and Portugal into darkness this week. Is renewable energy to blame? Also: US Health Secretary Robert F. Kennedy Jr alarms medical experts over his plans to impose placebo testing of vaccines. Plus: Steven Spielberg reveals what he thinks is the greatest film of all time. There is lots of scrutiny around renewable energies after the shock nationwide power outage that hit Spain and Portugal earlier this week. Spanish daily La Vanguardia asks that very question on the front page of its website: Who is to Blame for the Great Blackout? Was it a photovoltaic plant that shut down, a French disconnection, a poorly designed IT system or overconfidence in the system's infallibility? We still don't know what caused the blackout, but many have been quick to blame renewable energy for the system's failure. But in the same edition, La Vanguardia interviews the head of an energy research group, Jose Luis Dominguez, who says that Spain needs to continue investing in renewable energy. He concedes, though, that the blackout highlights the need for adjustments in regulation and oversight of companies. And that the low inertia of solar and wind energy requires more investment and innovation in reacting to unforeseen circumstances. That's the message echoed in an article from Reuters entitled "Don't blame renewables for Spain's power outage". Instead, the news agency says, Monday's blackout should be a warning to governments that investment in power storage and grid upgrades are just as important as expanding renewable energy projects.The US department of health is planning to change the way vaccines are tested and critics say the move could undermine public trust in immunisation. The Washington Post reports that Robert F. Kennedy Jnr wants to impose placebo testing in all new vaccines, in which people receive either the vaccine or an inert substance like a saline shot. Placebo testing is commonplace for new pathogens but not for well-researched diseases like measles and polio. Medical experts say this could be unethical because the placebo group would not receive a known effective intervention to a potentially deadly disease. The Post says the health department wants to increase transparency. Since Kennedy Jnr's appointment as head of health, the US top vaccine regulator Peter Marks has resigned under pressure, while Kennedy Jnr has continued to express his scepticism around vaccines amid an ongoing deadly measles outbreak in the US.The investigative journalism nonprofit collective Forbidden Stories has released a new report detailing the shocking treatment of Ukrainians in a Russian prison. Forbidden Stories is a collective which aims to continue the investigative reporting of journalists who have been silenced. Their Victoriia Project is named for Ukrainian journalist Victoriia Roshchyna's efforts to document the war in Ukraine. On her fourth trip in 2023, however, she never came back. Earlier this year, what has been identified as her body was delivered to Ukraine. Forbidden Stories details the treatment of Ukrainian prisoners of wars and in some cases, civilians at the notorious Taganrog prison. This is where Victoriia ended up. The articles describes the prison as "synonymous with the most violent types of treatment imaginable, reminiscent of the worst Soviet gulags". According to former inmates, beatings, unimaginable torture and food deprivation were routine occurrences at the prison. They also faced punishment for speaking Ukrainian and some inmates ended up committing suicide as a result of the torture.  In cinema news, Steven Spielberg has revealed what he thinks is the greatest film of all time. Screen Rant reports that the legendary director sys Francis Ford Coppola's 1972 film "The Godfather" was the greatest movie of all time. In fact, it was so good that it shook his confidence as a director and almost made him not want to become one, according to Spielberg. A few years later though, "Jaws" came out and Spielberg's career took off. He, like Coppola, is part of the New Hollywood group of directors who brought filmmaking into the modern era.Finally, a pair of tennis fans have got engaged in the stands before Alex de Minaur and Lorenzo Musetti's Round of 16 match in the Madrid Open. It brings a whole new meaning to "love game"!You can catch our press review every morning on France 24 at 7:20am and 9:20am (Paris time), from Monday to Friday.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Akeso's drug, Ivonescimab, has received approval in China as a competitor to Merck's Keytruda. However, its prospects in the US, where Summit owns the rights, are uncertain. Merck KGaA is acquiring SpringWorks for $3.9 billion to enhance its rare disease and oncology pipelines. Keytruda has shown promising results in reducing negative events in head and neck cancer patients. The cell and gene therapy sector faces challenges post-Marks FDA exit, including tariffs and workforce cuts.Transitioning to the next news, Trilink Biotechnologies introduces custom sets of mRNA for screening studies. Steminent Biotherapeutics is set to showcase a novel therapy for spinocerebellar ataxia. The cell and gene therapy sector is facing a critical period after the exit of FDA director Peter Marks, with threats such as tariffs and workforce cuts. Experts are uncertain about the future but are hopeful that Marks' legacy will continue under new FDA commissioner Marty Makary.Moving on to the upcoming American Association for Cancer Research meeting, which will feature presentations from companies like Merck and Boehringer Ingelheim that could impact cancer treatment. The industry in the U.S. is experiencing significant changes under the Trump administration, while conditions of regulatory and economic turmoil are more common in non-western markets. Makary's first interviews as FDA commissioner have raised questions about the accuracy of his statements.Lastly, the biopharma industry is also dealing with setbacks such as disappointing trial results and safety concerns. Overall, the sector is facing challenges but remains hopeful for the future under new leadership.

We’ve known for a while that there are two Anguses—both journalists covering oncology at health- and biopharma-focused news outlets. Now, for the first time, we’re bringing them together for a “Variety Studio: Actors on Actors”-style conversation. In this week’s episode of "The Top Line," Fierce Pharma Deputy Editor Angus Liu and STAT Cancer Reporter Angus Chen share insights into their work covering cancer and their thoughts on racial identity during a tumultuous time. They discuss what excites them most in the oncology field, how their reporting approaches differ and how they’ve often been mistaken for one another. To learn more about the topics in this episode: Judge permanently blocks NIH grant caps, prompting HHS appeal Cancer research, long protected, feels ‘devastating’ effects under Trump As Trump targets DEI practices, 4 pharmas reaffirm commitment to diversifying clinical trials For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty CAR-T cells can arm other immune cells with engineered proteins to fight cancer, study says See omnystudio.com/listener for privacy information.

Filmmakers Mikki Willis and Matt Guthrie open up about the making of Follow the Silenced—a bold new documentary that gives voice to those vaccine-injured and silenced during the COVID era. Featuring exclusive recorded calls with FDA's Dr. Peter Marks and CDC officials, the film reveals the hidden cost of government censorship. After fleeing California amid backlash, the filmmakers returned for a triumphant Hollywood premiere—where the film took home “Best of Fest” and “Best Director” at the Santa Monica Film Festival.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

On this week's episode, Eric Schmidt, Brad Loncar, Yaron Werber, Paul Matteis, and Nina Kjellson discuss impact of tariffs on biopharma relative to other sectors, FDA updates and bright spots, data, and fundraising. The episode opens with a conversation on tariffs and the upheaval and shifts at the FDA, including the departure of Peter Marks, former director of the FDA's Center for Biologics Evaluation and Research, which has the group concerned over loss of institutional memory, history, and the ability to meet deadlines. The conversation shifts to the measles outbreak, noting concerns about public health and future regulation due to HHS reorganization plans and perceived industry inaction. The group then discusses data, including Vaxcyte's underwhelming Phase 2b data, and hopes to avoid negative vaccine sentiment. Additionally, Eli Lilly's Phase 2 data for its siRNA-based therapeutic to lower lipoprotein(a) showed promising results and Amgen and Novartis are conducting their own Phase 3 trials for Lp(a). The episode concludes with a discussion on Isomorphic Labs, which raised over $600 million, with the group praising the investment in early-stage discovery science and expressed hope that it will facilitate the company's transformation of technology into drugs. *This episode aired on April 4, 2025.

Megyn Kelly is joined by FDA Commissioner Dr. Marty Makary for his first interview in his new position to discuss what he's learned since taking over the position 17 days ago, whether there are people in the building who are open to MAHA, what's currently working properly at the agency and what's not, the issues with the VAERS system, recent critiques from Peter Marks who left the agency, the need to ask questions in science and not jump to conclusions, his new policy limiting who can serve as members on FDA advisory committees, his efforts to counter the perception that the FDA has been captured by Big Pharma and other industries, how he learned first-hand about "the swamp," the apolitical work he and RFK are doing, his efforts to get certain drugs approved faster and to limit animal testing, the truth about the DOGE cuts and how no scientists or reviewers were cut, his relationship with RFK, his effort to redo the food pyramid, the efforts by RFK to get to the cause of autism, the need to look at environmental and dietary exposures that could alter the microbiome, and more. Grand Canyon University: https://GCU.eduLean: Visit https://TakeLean.com & use code MK20 for 20% offAncient Nutrition: Enjoy 25% off your first order at https://AncientNutrition.com/MEGYNFollow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at: https://www.devilmaycaremedia.com/megynkellyshow

First, from pesticide lawsuits to mRNA vaccine bans, Jefferey Jaxen breaks down major health freedom battles across the U.S. and abroad; Aaron Siri, Esq. & React19's Brianne Dressen expose new legal action against AstraZeneca; Filmmakers Mikki Willis & Matthew Guthrie reveal the truth behind Follow the Silenced; EXCLUSIVE: Secret recordings of Dr. Peter Marks admitting vaccine harm behind closed doors.PLUS: A shocking virtual timeline drops soon, featuring never-before-seen FDA docs and footage from the COVID-19 vaccine rollout.Visit TheRealPeterMarks.comPress conference + full timeline release: April 16, 2025#TheHighWire #ICAN #FollowTheSilenced #PeterMarks #VaccineInjuries #HealthFreedomGuests: Brianne Dressen, Aaron Siri, Esq., Matt Guthrie, Mikki WillisBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Measles is an extremely contagious disease. It's also extremely preventable. There's a vaccine. It's highly effective. For decades it has made measles outbreaks in the U.S. relatively rare, and measles deaths rarer still. But the U.S. has now seen more than 700 measles cases this year, and 3 deaths so far with active outbreaks across six states.The federal response is under scrutiny because Health and Human Services Secretary, Robert F. Kennedy, Jr. has made a career spreading false information about vaccines.What are this administration's views on vaccines, and what do they mean for what is already one of the worst U.S. measles outbreaks this century. Kennedy publicly promised he would support vaccines. Dr. Peter Marks, who was forced out as the nation's top vaccine regulator says his department isn't doing enough.For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

An extended version of Margaret Brennan's full interview with Dr. Peter Marks, the former head of FDA's Center for Biologics Evaluation and Research, a portion of which aired on "Face the Nation with Margaret Brennan" on April 13, 2025.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Health and Human Services Secretary Robert F. Kennedy Jr. is raising alarms in the scientific community. Kennedy declared during a recent cabinet meeting with President Trump that by September — just five months away — the federal government will determine the cause of autism and begin eliminating exposures he claims are to blame. Trump echoed the tone of Kennedy's remarks, stating, "There's gotta be something artificial out there that's doing this." But here's the problem: the science doesn't agree. While the root causes of autism remain complex, researchers widely agree it's influenced by a combination of genetics and environmental factors such as parental age and prenatal exposures — not vaccines. That vaccine-autism link has been repeatedly debunked by decades of peer-reviewed studies. Still, under Kennedy's leadership, the CDC has been ordered to reinvestigate vaccines and autism. Meanwhile, top FDA vaccine official Dr. Peter Marks resigned, accusing Kennedy of pushing misinformation and lies. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week on Face the Nation, President Trump's multi-front trade war whipsaws markets, and China fires back. What's next as the world's two biggest economic powers clash? Despite backing off of what he called "reciprocal tariffs" against dozens of countries, and announcing new exemptions on some key consumer products, the president is digging in on tariffs against China. We discuss what's next with U.S. Trade Representative Jamieson Greer. Then, we get a read on the broader economic impact from the president of the Federal Reserve Bank of Minneapolis, Neel Kashkari. Silicon Valley's Democratic Congressman Ro Khanna also joins us with reaction from the tech sector. Plus , we  have a new poll on how Americans think Trump is handling the economy. And finally, an update on the measles outbreak with the former top vaccine regulator with the FDA, Dr. Peter Marks. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In this explosive bonus episode of The Ultimate Assist, John Stockton and Ken Ruettgers welcome back health freedom advocate Brianne Dressen, a former AstraZeneca vaccine trial participant whose life was upended by a severe reaction. Brianne takes listeners inside her extraordinary year-and-a-half effort to sound the alarm on COVID vaccine injuries—directly to the FDA and NIH.Through seven recorded Zoom meetings with top federal health officials—including Dr. Peter Marks—she unveils the pattern of dismissal, gaslighting, and inaction that victims faced from the very agencies entrusted with public health. As Dressen puts it: “They listened, nodded, and did nothing.”This episode drops the veil on what was never supposed to be heard. With the release of these confidential recordings on TheRealPeterMarks.com, Brianne is putting the power back in the hands of the people.If you've ever questioned the narrative, this is the episode you can't miss.

About this episode: Last week, the Department of Health and Human Services abruptly fired around 10,000 employees, 3,500 of which were within the FDA alone—an organization of around 18,000 total employees as of January 2025. In this episode: A look at the work of the FDA and how it may be hampered by such significant cuts, and how patients may be among those most impacted. Guest: Dr. Robert Califf served as the FDA Commissioner under Presidents Barack Obama and Joe Biden. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Dr. Peter Marks's Resignation Letter (PDF)—The New York Times Widespread firings start at federal health agencies including many in leadership—NPR Shots The U.S. Food Safety System—Public Health On Call (June 2022) FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust—Public Health On Call (August 2022) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.  

It’s been a whirlwind week in public health. In this episode, host Steven Newmark breaks down a string of major developments coming out of the U.S. Department of Health and Human Services (HHS). From mass layoffs across HHS, including at the FDA, to the resignation of the country’s top vaccine regulator, these changes raise serious concerns—especially amid a rising measles outbreak. Tune in to hear what this means for patients, public health efforts, and the fight against vaccine hesitancy. Among the highlights in this episode: 00:50: Steven Newmark, Chief of Policy at GHLF, discusses HHS Secretary Robert F. Kennedy Jr.’s announcement of 10,000 staff layoffs, with the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) being the most impacted 01:31: Steven reflects on RFK Jr.'s earlier warning to FDA workers to "pack their bags" and discusses concerns about maintaining service levels with a 25% workforce cut 02:08: Quoting Robert Califf, Steven shares the demoralization felt by former and current HHS staff, calling out the treatment of hardworking public health employees 02:38: Steven shares concerns from Chiquita Brooks-LaSure, former Centers for Medicare & Medicaid Services (CMS) head, particularly around the likely impact of layoffs on already underfunded nursing home inspections 03:20: Steven reports the forced resignation of Dr. Peter Marks, the FDA’s top vaccine regulator, and the alarming response from the public health community 04:06: Steven details Dr. Marks’ warnings about leadership skepticism toward vaccines, especially in light of the growing measles outbreak 04:34: Steven gives an update on the measles outbreak in Texas and other states, citing more than 500 cases nationwide and highlighting RFK Jr.'s unscientific treatment suggestions like vitamin A and cod liver oil 05:16: Steven discusses how HHS cuts are hampering efforts to track infectious diseases and fund vaccine research, even as the outbreak fuels a shift toward pro-vaccine sentiment in affected areas 05:49: Steven urges listeners to get vaccinated and ensure those around them—especially children—are protected with the Measles, Mumps, and Rubella (MMR) vaccine Contact Our Host Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org A podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world.Pharmaceutical companies are pushing back against Trump's tariffs, requesting staggered tariffs as Trump plans for a more aggressive set of tariffs on April 2. Democrats are criticizing Trump's health cuts and policies, with lawsuits being filed and Senator Cory Booker speaking out against the administration. The FDA is facing turnover and layoffs, with concerns about the "revolving door" of talent between the agency and biopharma companies. Denali is making progress in crossing the blood-brain barrier for neuroscience treatments. In the midst of these developments, the biotech industry is seeing growth in cell and gene therapy investments. Despite these challenges, companies like Trilink are offering solutions for accelerating therapy discoveries with custom guide RNAs for CRISPR workflows.In other news, Peter Marks, head of the FDA's Center for Biologics Evaluation and Research, was forced out after clashing with Health and Human Services Secretary Robert F. Kennedy Jr. over transparency issues. Marks, known for his work on innovative therapies like cell and gene therapy, resigned due to the lack of desired truth and transparency from Kennedy. This event has caused turmoil in the biopharma industry, leading to a drop in biotech shares. Additionally, massive layoffs are expanding across HHS as part of Kennedy's plan to remove up to 10,000 staff members. The departure of Marks has raised concerns about the future of the FDA and the industry as a whole. Experts fear that the agency is losing institutional knowledge and experienced leaders, which could have negative implications for drug development and safety. Calls for Kennedy's dismissal have been made by analysts following Marks' resignation. The industry is now facing uncertainty and instability in the wake of these events.

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – Dr. Peter Marks, longtime FDA vaccine chief, is out—sparking scrutiny over his role in pushing COVID shots despite safety concerns. Billionaire doctor Patrick Soon-Shiong joins critics, calling for a return to honest medicine. From vaccine mandates to ignored cancer breakthroughs, this exposé reveals the deep flaws and corruption driving today's medical-industrial complex. Truth must come first.

Announcements: Science under siege, Thu Apr 3rd. @1:17 Political economist @2:48 Follow-ups: Catholic Charities @4:11 OK charter schools @ Ray Holmberg sentenced @5:30 West Virginia House of Delegates rejected SB 460 @9:26 Politics: David Geier to conduct study @10:55 Changes to SS @12:17 3rd term @24:44 News: Ozturk kidnapping @28:47 Religious liberty struggling all over @32:17 Religious Nonsense: Pew numbers @34:48 Faith healing parents convicted @36:30 WI election results @39:32 Black Mass in KS @40:40 Health/Medicine/Science: West Texas Vit A @49:03 Kevin Griffis CDC @56:16 RFK Jr. forces out Peter Marks, FDA's top vaccine scientist @56:56 Vaccine funding dropped @57:20 Shingles vaccine study @58:11 HHS to drop 10k jobs @59:02 Scientists leaving? @59:41 Can you move elsewhere?? @1:00:38 UTAH! @1:04:28 Final Stories: Virginia Giuffre @1:11:59

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – Dr. Peter Marks, longtime FDA vaccine chief, is out—sparking scrutiny over his role in pushing COVID shots despite safety concerns. Billionaire doctor Patrick Soon-Shiong joins critics, calling for a return to honest medicine. From vaccine mandates to ignored cancer breakthroughs, this exposé reveals the deep flaws and corruption driving today's medical-industrial complex. Truth must come first.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Former FDA Commissioner Robert Califf has spoken out as layoffs continue at the FDA, with the latest cuts affecting the Center for Drug Evaluation and Research (CDER). The layoffs are part of a larger reduction of 10,000 jobs at the Department of Health and Human Services. In addition, biopharma markets are in chaos following the departure of Peter Marks from the FDA's Center for Biologics Evaluation and Research (CBER).Carisma Therapeutics has laid off most of its staff and is considering selling off assets and winding down fully. Analysts are calling for President Donald Trump to reconsider his appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services. The departure of Peter Marks from the FDA has caused shares in the biopharma markets to tumble.Trilink offers custom guide RNAs (grRNAs) for CRISPR-based therapy discoveries. Despite market challenges, the cell and gene therapy sector has seen a 30% investment surge. Companies like Tenaya are cutting their workforce to fund development of gene therapies.Overall, the biopharma industry is facing uncertainty and instability as layoffs continue and key figures depart from regulatory agencies.

Biopharma's reaction to the forced resignation of venerable CBER director Peter Marks has been swift and furious, with former FDA Commissioner Robert Califf saying on LinkedIn that “the FDA as we've known it is finished.” Analysts, meanwhile, called Marks' exit “arguably biotech investors' greatest fear,” as company shares across the industry tumbled.   Marks' announcement added insult to injury for the agency, which was already reeling from the announced cuts of 10,000 employees across the Department of Health and Human Services, including 3,500 FDA staffers. Those layoffs began to roll out on Tuesday as some employees showed up to work only to discover they no longer had a job. Amid all this chaos, Cantor Fitzgerald analysts called for Kennedy himself to get the axe, saying in part that he was “undermining the trusted leadership of health care in this country.”    Despite the turmoil, drug development continues in the obesity space, with Novo Nordisk presenting mixed data from its semaglutide franchise at the American College of Cardiology's annual conference last weekend. While an oral version of the blockbuster drug showed cardiovascular benefits for some patients, it failed to change the trajectory of other major adverse cardiovascular events. Meanwhile, Novo continues its battle against compounding pharmacies manufacturing copycat versions of semaglutide—as multiple players scramble for a piece of this massive pie.    On the Alzheimer's front, Eli Lilly's Kisunla failed last week to win the recommendation of the EU's Committee for Medicinal Products for Human Use. This decision is consistent with CHMP's recent stance on anti-amyloid antibodies, as Biogen and Eisai have also struggled to get Leqembi approved in Europe.    On a positive note, pharma R&D returns grew again in 2024, but Deloitte warned that this progress is “fragile.” The firm urged companies to be bold and embrace cutting edge technology like gene therapy and AI. These returns can't help everyone, however, as the past week has seen an uptick in layoffs across biopharma, including at Carisma Therapeutics, Organon and Tenaya Therapeutics.   Finally, as April kicks off cancer conference season, BioSpace took a deep dive into the recent action in the always-hot in radiopharmaceuticals space.  

Mike & Nick on the student visas that have been revoked by the State Department across the country, a look at some of these stories, writer Ken Reid joins to discuss his recent article on two other instances where this took place under other U.S. Presidents, plus, who is Dr. Peter Marks and why is his resignation important. This episode is brought to you by - Fresh Roasted Coffee - Have a cup of the best tasting coffee that gets Mike & Nick through breaking down the latest in news & politics!  Visit our link - https://lddy.no/1hvgr & use our promo code CANWEPLEASEGET20 for 20% off your first purchase.And by SeatGeek.  NBA, NHL, MLB, concerts, you name it, SeatGeek has the tickets! Go to seatgeek.com or download the SeatGeek app and use our promo code CANWEPLEASETALK at checkout to get $20 off that ticket purchase!Support this show http://supporter.acast.com/can-we-please-talk. Become a member at https://plus.acast.com/s/can-we-please-talk. Hosted on Acast. See acast.com/privacy for more information.

Peter Marks' resignation from the FDA, pushed by RFK Jr., is a win for those who believe in accountability and transparency in government agencies. Marks played a key role in the rushed approval of COVID-19 vaccines, prioritizing Big Pharma’s interests over the American people's right to informed consent and medical freedom. His departure signals a much-needed shake-up in the bureaucratic machine that has long operated without oversight, rubber-stamping experimental treatments while silencing dissent. This is a victory against government overreach and corporate collusion, proving that public pressure can still hold unelected officials accountable. The Wellness Company prides itself on pushing back against censorship and tyranny. It's why it has developed a series of prescription drug medical emergency kits that prescribed directly to you and delivered to your door to use incase of an emergency. You will have on hand much needed antibiotics, antivirals and antiparasitics, including Ivermectin. Please visit TWC.Health/Grant and use the promo code "Grant" for 10% off. See omnystudio.com/listener for privacy information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Sanofi and Alnylam have received FDA approval for the first RNAi treatment for hemophilia, with the drug, Qfitlia, indicated for both hemophilia A and B. This approval is significant as it can be given regardless of the presence of neutralizing antibodies against clotting factors VIII or IX. However, the sudden departure of FDA director Peter Marks has caused uncertainty in the biopharma industry. In other news, Vertex has cut a diabetes asset but analysts remain optimistic about their phase III option. Lilly's RNA silencer has shown promising results in lowering a key cardiovascular biomarker. Trilink is offering custom guide RNAs for CRISPR workflow to accelerate therapy discoveries. Despite market challenges, the cell and gene therapy sector has seen a 30% investment surge. Companies like Amgen, Aldeyra, and Argenx are among those with upcoming FDA actions. Arbutus has announced layoffs, while big pharmas are pushing boundaries in radiopharmaceuticals. Michelle Werner of AltoRNA is focused on making better drugs. Safety questions are looming in Duchenne as Dyne and Wave plan FDA filings. There are job opportunities available in data management and program leadership within the biopharma industry.Moving on to other news, several big pharmaceutical companies such as Novartis, Bayer, AstraZeneca, Bristol Myers Squibb, and Eli Lilly are competing in the radiopharmaceuticals market, which is projected to be worth over $13 billion by 2033. The FDA is expected to announce decisions on therapies for dry eye disease soon. Michelle Werner, CEO of AllTrna, is focused on developing trna-based treatments for various diseases.Safety concerns are emerging in the Duchenne muscular dystrophy space as companies like Dyne and Wave plan FDA filings. The EU rejected Lilly's Alzheimer's drug Kisunla, Biontech's bispecific showed promise in treating SCLC patients, and Wave's duchenne exon-skipper reversed muscle damage in a mid-stage trial. Job opportunities within the biopharma industry were also highlighted for those interested.Thank you for tuning in to Pharma and Biotech daily - keeping you updated on all the latest news in the world of pharmaceuticals and biotechnology.

The FDA removed its chief tobacco regulator, Brian King, amid significant cuts across the agency. King, disappointed by his placement on administrative leave, saw multiple employees in the FDA's tobacco center also receive termination notices. His tenure included actions against flavored e-cigarettes, contributing to a decline in teen vaping rates. This leadership change follows the ousting of vaccine chief Dr. Peter Marks, with plans to eliminate 3,500 FDA positions targeting scrutiny of childhood vaccines and ultra-processed foods. Incoming commissioner Marty Makary will face challenges managing an agency that has lost many experts. Tobacco-related diseases remain a major public health concern despite lower smoking rates. Criticism of the FDA's tobacco center has heightened from lawmakers and public health advocates, while the tobacco industry pushes for faster approvals of e-cigarettes. Under King's leadership, several flavored e-cigarette applications faced rejection, resulting in legal challenges against the FDA.Learn more on this news visit us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

In their most urgent and emotionally charged episode yet, Dr. Jonathan Howard and science journalist Wendy Orent confront the accelerating unraveling of public health institutions in the United States under the RFK Jr. administration. They open with a flood of disturbing headlines: Peter Marks, the nation's top vaccine expert, has been ousted. Measles is surging in Texas, and children are arriving at hospitals with liver failure after being treated with toxic vitamin A overdoses—recommended by RFK-aligned influencers. The CDC and NIH are being gutted: funding pulled, scientists fired, and research into vaccine hesitancy and mRNA technology halted. David Geier, a disgraced figure with a history of chemically castrating autistic children, has been tapped to lead a new federal vaccine safety study. Howard and Orent don't hold back. They rip into this dystopian reversal of public health, where disinformation peddlers are now calling the shots. They highlight the sheer absurdity and danger of putting figures like Jay Bhattacharya, Scott Atlas, and Geier in positions of power—people who have spent years sowing distrust in vaccines, downplaying COVID, and demonizing public health measures. The episode draws a brutal contrast between the lived reality of frontline doctors and essential workers—many of whom died in early pandemic waves—and the self-styled martyrs of the anti-lockdown movement, who now paint themselves as victims. One particularly enraging example: Bhattacharya's claim that he felt “unsafe” on Stanford's campus after a flyer was posted with his own quote alongside Florida's Delta wave death tolls. This, while over 20,000 Floridians died in that wave, many unvaccinated due to the policies he championed. A major target of their critique is the book In COVID's Wake, which they say rewrites history by glorifying the authors of the Great Barrington Declaration and ignoring the real human toll of their misinformation. Orent and Howard dismantle the book's central claim—that these anti-lockdown figures were treated unfairly—pointing out that many of them became media darlings, got promoted, or were appointed to powerful roles. Meanwhile, real scientists and doctors who fought on the frontlines were ignored, censured, or worse. They also expose the cynical “woke-washing” by these same figures—claiming to champion the poor and marginalized while promoting policies that left essential workers unprotected. Their concern for “equity,” Howard and Orent argue, was nothing more than rhetorical cover for libertarian, laissez-faire ideology. As the episode barrels toward its conclusion, one message becomes chillingly clear: We are watching the active dismantling of public health—science silenced, disinformation rewarded, and truth replaced by ideology. And as Dr. Howard puts it: “If we had predicted these headlines six months ago, we would've sounded insane. But now, they're reality.” This episode is a searing call to action. For scientists. For journalists. For anyone who still believes in truth, public health, and protecting the vulnerable. Because as Orent warns: “The wild horses of the plague apocalypse are descending... and the party's just beginning.”   Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

The FDA’s top vaccine official has resigned. On Friday, Dr. Peter Marks wrote that Health Secretary Robert F. Kennedy Jr. wants “subservient confirmation of his misinformation and lies.” That follows this week’s announcement that the Department of Health and Human Services would fire around 10,000 of its workers. Ali Rogin speaks with two former HHS leaders about what this means for the country. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.    

Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.     

Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.   

Tech guru  Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology. 

Nightlife Tech Guru Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.

In this episode, we talk with Peter Marks, former chief theater critic for The Washington Post, about his transition from legacy media to independent content creation on Substack. Reflecting on decades in journalism, Peter examines how the role of the theater critic may be changing, yet the value of thoughtful criticism remains essential for shaping conversations and elevating art.We explore how to sustain meaningful, long-form storytelling in an age of short attention spans, as well as the timeless power of word of mouth and trust in bringing attention to art and ideas. Peter also shares how this new chapter allows him to connect his diverse passions and reimagine his creative path.This conversation is a compelling look at creative reinvention, the evolving media landscape, and the enduring relevance of critical voices in the arts.Marks & Vincentelli Podcasthttps://marksvincentelli.substack.com/podcastEPISODE #54 of CREATIVE RISKJoin our Patreon for ad-free early access to episodes, exclusive discounts, weekly Q&As, and so much more. Visit https://www.patreon.com/CreativeRiskPodcast today!Submit your story to Raw & Rising, the mini-series spotlighting hustling creatives—those self-producing, diversifying their income, and tackling challenges head-on. Visit www.artists-strategy.com/creative-risk to pitch your story today. Artist Tax Prep: Affordable tax preparation services for artists & others with self-employment income. "I've been working with them for a few years now and love them." - MikeArtist Tax Prep Websitehttps://www.artisttaxprep.com/Artist Tax Prep Instagramhttps://www.instagram.com/artisttaxprep/Email info@artisttaxprep.com and mention Creative Risk for a free 15 minute "fit check." —Thanks for listening!Join our email list for our weekly newsletter with deep insight on our personal artistic journeys: www.artists-strategy.com/signupSubscribe on Apple Podcasts: podcasts.apple.com/us/podcast/creative-risk/id1706381310Subscribe on Spotify: open.spotify.com/show/5hzvD8HgCjOo1NcA5zBDN4?si=404a2369523a45cbFollow Us on IG: www.instagram.com/creativeriskpod/Follow Us on TikTok: www.tiktok.com/@creativeriskpod— “CREATIVE RISK”, is a new podcast hosted by actors Joshua Morgan and Mike Labbadia of Artist's Strategy where they explore all things art, entrepreneurialism and everything in between. The acting industry is more volatile and competitive than ever before, therefore the artist must evolve in order to take radical ownership over their creative businesses. Each episode, Mike and Joshua will get raw and unfiltered, giving hot takes and cutting edge strategies on how to build a sustainable career in the arts.

Nightlife Tech Guru Peter Marks, a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.